Niche Immune Modulation Cerberus Therapeutics focuses on nanobody-based therapeutics to modulate the immune system, presenting a targeted opportunity to partner with immunology-focused programs and autoimmune/infectious disease initiatives.

Small Team Agility With a lean team of 2-10 employees, Cerberus offers opportunities for agile collaborations, streamlined decision-making, and faster pilot program onboarding for strategic partnerships and joint ventures.

Early Stage Revenue Reported revenue in the low-to-mid seven figures signals a startup with market validation and potential for scalable partnerships, licensing, or milestone-based collaborations with larger biotechs.

Founder Expertise Founded on decades of work by renowned scientists, the company can leverage credibility for co-development deals, advisory roles, and access to exclusive IP discussions with potential licensees.

Digital & Outreach Readiness Existing tech stack and online presence indicate readiness for targeted digital outreach, lead generation, and content-driven campaigns to attract interest from immunology, infectious disease, and biotech development teams.